Quintiles IMS Market Access Summit

Views & Analysis

Access to new medicines is not high up the list of priorities for NHS England, but pharma must seize opportunities to promote innovation uptake.

News

Buoyed by positive data in a phase 2 trial, GSK will start a phase 3 programme for an mRNA-based flu shot targeting both HA and NA flu antigens.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.